TITLE

The ADDITION-Cambridge trial protocol: a cluster - randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

AUTHOR(S)
Echouffo-Tcheugui, Justin B.; Simmons, Rebecca K.; Williams, Kate M.; Barling, Roslyn S.; Prevost, A. Toby; Kinmonth, Ann Louise; Wareham, Nicholas J.; Griffin, Simon J.
PUB. DATE
January 2009
SOURCE
BMC Public Health;2009, Vol. 9 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The increasing prevalence of type 2 diabetes poses a major public health challenge. Population-based screening and early treatment for type 2 diabetes could reduce this growing burden. However, the benefits of such a strategy remain uncertain. Methods and design: The ADDITION-Cambridge study aims to evaluate the effectiveness and cost effectiveness of (i) a stepwise screening strategy for type 2 diabetes; and (ii) intensive multifactorial treatment for people with screen-detected diabetes in primary care. 63 practices in the East Anglia region participated. Three undertook the pilot study, 33 were allocated to three groups: no screening (control), screening followed by intensive treatment (IT) and screening plus routine care (RC) in an unbalanced (1:3:3) randomisation. The remaining 27 practices were randomly allocated to IT and RC. A risk score incorporating routine practice data was used to identify people aged 40-69 years at high-risk of undiagnosed diabetes. In the screening practices, high-risk individuals were invited to take part in a stepwise screening programme. In the IT group, diabetes treatment is optimised through guidelines, target-led multifactorial treatment, audit, feedback, and academic detailing for practice teams, alongside provision of educational materials for newly diagnosed participants. Primary endpoints are modelled cardiovascular risk at one year, and cardiovascular mortality and morbidity at five years after diagnosis of diabetes. Secondary endpoints include all cause mortality, development of renal and visual impairment, peripheral neuropathy, health service costs, self-reported quality of life, functional status and health utility. Impact of the screening programme at the population level is also assessed through measures of mortality, cardiovascular morbidity, health status and health service use among high-risk individuals. Discussion: ADDITION-Cambridge is conducted in a defined high-risk group accessible through primary care. It addresses the feasibility of population-based screening for diabetes, as well as the benefits and costs of screening and intensive multifactorial treatment early in the disease trajectory. The intensive treatment algorithm is based on evidence from studies including individuals with clinically diagnosed diabetes and the education materials are informed by psychological theory. ADDITION-Cambridge will provide timely evidence concerning the benefits of early intensive treatment and will inform policy decisions concerning screening for type 2 diabetes.
ACCESSION #
43226995

 

Related Articles

  • Forecasting future prevalence of type 2 diabetes mellitus in Syria. Al Ali, Radwan; Mzayek, Fawaz; Rastam, Samer; Fouad, Fouad M.; O'Flaherty, Martin; Capewell, Simon; Maziak, Wasim // BMC Public Health;2013, Vol. 13 Issue 1, p1 

    Background: Type 2 diabetes mellitus (T2DM) is increasingly becoming a major public health problem worldwide. Estimating the future burden of diabetes is instrumental to guide the public health response to the epidemic. This study aims to project the prevalence of T2DM among adults in Syria over...

  • Pierwotna prewencja cukrzycy typu 1. Stan obecny i perspektywy. Wąsikowa, Renata B.; Basiak, Aleksander // Pediatric Endocrinology, Diabetes & Metabolism;2012, Vol. 18 Issue 4, p147 

    The authors presented a review of the actual literature of primary prevention of type 1 diabetes. They stressed a dramatic increase of patients with newly diagnosed diabetes, which was called an epidemic of the XXI century. According to the recently published data, the increase of newly...

  • Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Sözmen, Kaan; Unal, Belgin; Capewell, Simon; Critchley, Julia; O'Flaherty, Martin // International Journal of Public Health;Jan2015 Supplement, Vol. 60, p13 

    Objectives: The purpose of this study is to estimate the prevalence and the number of people with type 2 diabetes (T2DM) in 2025 in Turkey and to evaluate the impact of possible policy options on T2DM prevalence. Methods: We developed a model to predict future prevalence of T2DM using trend data...

  • Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients. Chen, Szu-Chia; Hsiao, Pi-Jung; Huang, Jiun-Chi; Lin, Kun-Der; Hsu, Wei-Hao; Lee, Yu-Li; Lee, Mei-Yueh; Chang, Jer-Ming; Shin, Shyi–Jang // PLoS ONE;7/31/2015, Vol. 10 Issue 7, p1 

    Although some studies have reported that low ankle-brachial index (ABI) is associated with diabetic retinopathy (DR) in diabetic patients, it remains controversial as to which stage of DR. The aim of this study is to assess whether peripheral artery disease (PAD), indicated by abnormally low or...

  • Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus. Annemans, L.; Marbaix, S.; Webb, K.; Van Gaal, L.; Scheen, A. // Clinical Drug Investigation;2010, Vol. 30 Issue 2, p133 

    Background and Objective: Patients with type 2 diabetes mellitus have a high risk of developing cardiovascular (CV) disease. The clinical benefit of use of statins in patients with type 2 diabetes has been demonstrated in several randomized, controlled trials, including the CARDS clinical trial....

  • Does Screening for Type 2 Diabetes Pay Off? Kuritzky, Louis // Infectious Disease Alert;Feb2013 Clinical Briefs in Primary Care, p3 

    The article discusses a study conducted by a team which included R. K. Simmons and published in an issue of the "Lancet" which offers an analysis of the screening for type 2 diabetes and population mortality over ten years.

  • AN INTRODUCTION TO MACRO-LEVEL SPATIAL NONSTATIONARITY: A GEOGRAPHICALLY WEIGHTED REGRESSION ANALYSIS OF DIABETES AND POVERTY. Siordia, Carlos; Saenz, Joseph; Tom, Sarah E. // Human Geographies -- Journal of Studies & Research in Human Geog;Nov2012, Vol. 6 Issue 2, p5 

    Type II diabetes is a growing health problem in the United States. Understanding geographic variation in diabetes prevalence will inform where resources for management and prevention should be allocated. Investigations of the correlates of diabetes prevalence have largely ignored how spatial...

  • Sıklığı Artan Bir Halk SaÄŸlığı Sorunu: Non-Alkolik YaÄŸlı KaraciÄŸer Hastalığı. Kara, Muammer; Erdal, Muhammed // TAF Preventive Medicine Bulletin;2014, Vol. 13 Issue 1, p65 

    Non-alcoholic fatty liver disease (NAFLD), is a liver disease, that occur in non alcohol users, with same histological features of alcoholic liver disease. The increased importance of NAFLD is depends on its close relation of current problems such as Type 2 Diabetes Mellitus and hyperlipidemia,...

  • Glycosylated Hemoglobin: The Importance in Management of Type 2 Diabetes. Yavari, Abbas // Journal of Stress Physiology & Biochemistry;2011, Vol. 7 Issue 4, p122 

    Type 2 diabetes is a major public health problem with high and increasing prevalence, morbidity and mortality. The association between diabetes and microvascular and macrovascular complications is well known besides, tight glycemic control is a necessity. HbA1C has clinically been used since...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics